Ar - Grapevine Kidney Center, Llc is a medicare approved dialysis facility center in Grapevine, Texas and it has 20 dialysis stations. It is located in Tarrant county at 1270 William D. Tate Ave, Grapevine, TX, 76051. You can reach out to the office of Ar - Grapevine Kidney Center, Llc at (817) 421-6326. This dialysis clinic is managed and/or owned by American Renal Associates. Ar - Grapevine Kidney Center, Llc has the following ownership type - Profit. It was first certified by medicare in November, 2017. The medicare id for this facility is 672837 and it accepts patients under medicare ESRD program.
| Name | Ar - Grapevine Kidney Center, Llc |
|---|---|
| Location | 1270 William D. Tate Ave, Grapevine, Texas |
| No. of Dialysis Stations | 20 |
| Medicare ID | 672837 |
| Managed By | American Renal Associates |
| Ownership Type | Profit |
| Late Shifts | No |
| 1270 William D. Tate Ave, Grapevine, Texas, 76051 | |
| (817) 421-6326 | |
| Not Available |
News Archive
Genetic manipulation of exosomes, virus-sized particles released by all cells, may offer a new therapeutic approach to treating pancreatic cancer, according to a study at The University of Texas MD Anderson Cancer Center.
A disaster or tragedy is unexpected and often brings out strong emotions. The Disaster Distress Helpline 1-800-985-5990 can provide immediate counseling to anyone who needs help in dealing with the tragedy in Boston.
A young pharmacy graduate has been awarded national recognition for her pioneering research in the field of genetics which has the potential to treat diseases such as cancer and Parkinson's.
The health care industry funded "8,700 trips by Department of Defense personnel" from 1998 to 2007, at a cost of more than $10 million, the Center for Public Integrity reports.
Concert Pharmaceuticals, Inc. announced today the presentation of Phase 1 data on CTP-347, a deuterium-modified analog of paroxetine for the treatment of hot flashes. Concert presented the results during a poster session at the American College of Clinical Pharmacology's 38th Annual Meeting.
› Verified 3 days ago
| NPI Number | 1235596446 |
| Organization Name | Grapevine Regional Dialysis Center |
| Doing Business As | Grapevine Kidney Center Llc |
| Address | 1270 William D Tate Ave Grapevine, Texas, 76051 |
| Phone Number | (817) 421-6326 |
News Archive
Genetic manipulation of exosomes, virus-sized particles released by all cells, may offer a new therapeutic approach to treating pancreatic cancer, according to a study at The University of Texas MD Anderson Cancer Center.
A disaster or tragedy is unexpected and often brings out strong emotions. The Disaster Distress Helpline 1-800-985-5990 can provide immediate counseling to anyone who needs help in dealing with the tragedy in Boston.
A young pharmacy graduate has been awarded national recognition for her pioneering research in the field of genetics which has the potential to treat diseases such as cancer and Parkinson's.
The health care industry funded "8,700 trips by Department of Defense personnel" from 1998 to 2007, at a cost of more than $10 million, the Center for Public Integrity reports.
Concert Pharmaceuticals, Inc. announced today the presentation of Phase 1 data on CTP-347, a deuterium-modified analog of paroxetine for the treatment of hot flashes. Concert presented the results during a poster session at the American College of Clinical Pharmacology's 38th Annual Meeting.
› Verified 3 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.